WPRIM Management System> DCMS> International Journal of Cerebrovascular Diseases> > 29

Volume: 29

1. Effect of white matter hyperintensities location on clinical outcomes in patients with acute ischemic stroke treated with intravenous thrombolysis Page:1—5
2. Correlation between white matter hyperintensities and stroke etiology classification in patients with acute isolated penetrating artery territory infarction Page:6—12
3. Risk factors for symptomatic intracranial atherosclerotic stenosis: a comparison of anterior circulation and posterior circulation Page:13—17
4. Clinical features of direct carotid cavernous fistulas: comparison with indirect carotid cavernous fistulas Page:18—23
5. Diagnostic value of white matter hyperintensities in temporal pole and external capsule for CADASIL: a Meta-analysis Page:24—31
6. Hyperglycemia and outcomes of patients with ischemic stroke after reperfusion therapy Page:32—37
7. Perioperative blood pressure management in patients with acute ischemic stroke treated with endovascular therapy Page:38—42
8. Post-stroke fatigue Page:43—47
9. Enlarged perivascular space Page:48—52
10. Effect of leucine-rich α2-glycoprotein-1 on ischemic stroke by regulating transforming growth factor β signaling pathway Page:53—57
11. Role of p75 neurotrophin receptor in neuronal apoptosis after cerebral ischemia Page:58—63
12. Role of miRNAs in ischemic brain injury Page:64—68
13. Transient ischemic attack and ischemic stroke: definition, commonality and inspiration Page:69—74
14. Evaluation of characteristics of carotid plaques and immediate outcomes after carotid artery stenting in diabetic and non-diabetic patients by optical coherence tomography Page:81—87
15. Correlation between vascular remodeling pattern and perforator stroke after stenting in patients with symptomatic intracranial vertebrobasilar artery stenosis Page:88—94
16. Eosinophils predict short-term outcomes in patients with acute ischemic stroke Page:95—99
17. Correlation between heart rate variability and cerebral small vessel disease in patients with obstructive sleep apnea Page:100—105
18. Correlation between heart rate variability and cognitive impairment in patients with obstructive sleep apnea Page:106—113
19. Matrix metalloproteinase-9 and neutrophil to lymphocyte ratio predict delayed perihematomal edema in patients with spontaneous intracerebral hemorrhage Page:114—119
20. Long non-coding RNA H19: a therapeutic target for ischemic stroke Page:120—125
21. Roles of circular RNAs in ischemic stroke Page:126—131
22. Role of exosomes in neuroinflammation after cerebral ischemia Page:132—137
23. Lipoprotein (a) and ischemic stroke Page:138—141
24. Ezetimibe in the prevention of ischemic stroke Page:142—147
25. Dietary inflammatory index and white matter hyperintensities Page:148—151
26. Thyroid autoantibodies and intracranial artery stenosis Page:152—155
27. Correlation between fluid attenuation inversion recovery vascular hyperintensities-diffusion weighted imaging mismatch and the outcomes of endovascular mechanical thrombectomy in patients with middle cerebral artery M1 segment occlusive stroke Page:161—168
28. Mean platelet volume predicts the outcomes in patients with acute ischemic stroke treated with intravenous thrombolysis Page:169—173
29. Correlation between subclinical hypothyroidism and outcomes of patients with acute ischemic stroke Page:174—178
30. Correlation between blood pressure changes within 24 h after intravenous thrombolysis and the outcome in patients with acute ischemic stroke Page:179—183
31. Predictive value of circulating miR-143 and miR-182 for the outcome in patients with acute ischemic stroke Page:184—188
32. Correlation between low-density lipoprotein cholesterol and hemorrhagic transformation after intravenous thrombolysis in patients with acute ischemic stroke Page:189—193
33. Long-term butylphthalide pretreatment attenuates ischemic brain injury in mice with permanent distal middle cerebral artery occlusion through Nrf2 pathway Page:194—200
34. Predictive factors for futile recanalization of acute anterior circulation ischemic stroke after endovascular treatment Page:201—205
35. Enlarged perivascular space and post-stroke cognitive impairment Page:206—209
36. Secondary prevention of embolic stroke of undetermined source Page:210—215
37. Imaging signs for predicting hematoma enlargement in patients with intracerebral hemorrhage Page:216—222
38. Treatment of chronic internal carotid artery occlusion and its effect on cognitive function Page:223—227
39. Pregnancy-specific risk factors for pregnancy-related ischemic stroke Page:228—231
40. Clinical characteristics and outcomes of wake-up stroke Page:241—245
41. Effectiveness and safety of tirofiban combined with intravenous thrombolysis in the treatment of elderly patients with acute ischemic stroke Page:246—251
42. Risk factors for refeeding syndrome in patients with severe stroke Page:252—257
43. Correlation between cerebral microbleeds and lacunar infarction in patients with cerebral small vessel disease Page:258—264
44. Correlation between serum vascular endothelial growth factor, miR-126 and cerebral microbleeds Page:265—271
45. Correlation between serum procalcitonin level and intracranial atherosclerotic burden in patients with ischemic stroke Page:272—276
46. Liquiritin improves depressive behavior in rats with post-stroke depression by reducing apoptosis of amygdala cells Page:277—284
47. Prehospital delay and its influencing factors in acute ischemic stroke Page:285—290
48. Predictive role of neutrophil to lymphocyte ratio in patients with ischemic stroke receiving reperfusion therapy Page:291—293
49. In-stent restenosis of carotid artery Page:294—297
50. Predictors of post-stroke cognitive impairment Page:298—302
51. Effect of transcranial direct current stimulation on post-stroke cognitive impairment Page:303—306
52. Intestinal flora and ischemic stroke Page:307—313
53. Risk factors and early neurological deterioration in proximal single subcortical infarction: comparison with distal single subcortical infarction Page:321—325
54. Correlation of fluid-attenuation inversion recovery vascular hyperintensity and clinical outcome in patients with middle cerebral artery M1 occlusive stroke Page:326—330
55. Renal function and brain frailty in patients with mild stroke or transient ischemic attack Page:331—336
56. Combination of conventional axial and thin-layer sagittal diffusion-weighted imaging to improve the detection ability of acute brainstem infarction Page:337—341
57. Predictive value of high-sensitivity C-reactive protein for hematoma enlargement in patients with intracerebral hemorrhage Page:342—346
58. Hyperhomocysteinemia is a risk factor for intracranial aneurysms Page:347—350
59. Blood pressure rhythm and circadian clock protein expression after cerebral ischemia-reperfusion in spontaneously hypertensive rats Page:351—357
60. Is intravenous thrombolysis necessary before mechanical thrombectomy for acute ischemic stroke? Page:358—363
61. Parenchymal hyperdensities after endovascular mechanical thrombectomy for acute ischemic stroke Page:364—369
62. Application of remote ischemic conditioning in patients with acute ischemic stroke Page:370—377
63. Von Willebrand factor-glycoprotein Ⅰb axis and ischemic stroke Page:378—381
64. Regulatory effect of microRNAs on neuroplasticity of ischemic stroke Page:382—387
65. Cognitive impairment in patient with intracerebral hemorrhage Page:388—391
66. High-resolution magnetic resonance imaging vascular wall characteristics and risk of ischemic stroke in patients with middle cerebral artery atherosclerotic stenosis Page:401—406
67. Correlation between collateral circulation and infarct pattern and outcome in acute ischemic stroke patients with anterior circulation intracranial atherosclerosis Page:407—413
68. Clinical significance of FLAIR vascular hyperintensities in patients with chronic atherosclerotic middle cerebral artery occlusion Page:414—419
69. Correlation between MTHFR gene C677T polymorphism, homocysteine and early neurological deterioration in Han population with acute ischemic stroke in Chengdu area Page:420—425
70. Treatment of hemiplegic stroke warning syndrome: comparison between tirofiban and aspirin combined with clopidogrel Page:426—431
71. Correlation between hyperuricemia and outcome in patients with acute ischemic stroke Page:432—436
72. Cancer-associated ischemic stroke: pathophysiology, clinical characteristics, and treatment Page:437—441
73. Chronic kidney disease and ischemic stroke Page:442—447
74. Cryptogenic stroke in patients with patent foramen ovale: potential mechanisms and prevention strategies Page:448—451
75. Enlarged perivascular spaces and post-stroke cognitive impairment Page:452—457
76. Role of cerebral veins in ischemic stroke Page:458—462
77. Role of pericytes in the pathogenesis of cerebral small vessel disease Page:463—466
78. Mechanism of microglia involved in the pathophysiology of brain white matter hyperintensity Page:467—470
79. Hemodynamic evaluation of intracranial atherosclerotic lesions based on computational fluid dynamics Page:471—475
80. Effect of blood pressure variability within 24 h after endovascular thromboectomy on early neurological improvement in patients with acute ischemic stroke Page:485—490
81. Plasma Dickkopf-1 predicts early neurological deterioration and outcome in patients with acute ischemic stroke Page:491—496
82. iScore and serum homocysteine predict early neurological deterioration in patients with acute ischemic stroke Page:497—502
83. Effect of carotid artery stenting on cognitive function in patients with severe carotid artery stenosis Page:503—506
84. Graeb score predicts the outcome of high-grade aneurysmal subarachnoid hemorrhage patients with intraventricular hemorrhage Page:507—513
85. Dual antiplatelet therapy for mild stroke and transient ischemic attack Page:514—520
86. Risk factors for clopidogrel resistance Page:521—525
87. Diabetes mellitus and post-stroke cognitive impairment Page:526—531
88. Neutrophil to lymphocyte ratio and vascular cognitive impairment Page:532—536
89. Effect of CX3CL1/CX3CR1 in cerebral ischemia and its mechanisms Page:537—543
90. Role and mechanism of mixed lineage kinase domain-like protein in cerebral ischemia Page:544—548
91. Role and mechanism of microglia in early brain injury after subarachnoid hemorrhage Page:549—554
92. Influence of the use of the intermediate catheter on the outcome of patients with acute ischemic stroke after endovascular treatment Page:565—569
93. Fasting blood glucose predicts the outcome after intravenous thrombolytic therapy in patients with severe acute ischemic stroke Page:570—575
94. Predictors of clinically important stress-related gastrointestinal bleeding after acute stroke and their impact on short-term outcome Page:576—582
95. Neutrophil to lymphocyte ratio predicts hemorrhagic transformation in patients with acute ischemic stroke Page:583—588
96. Predictive value of C-reactive protein to lymphocyte ratio for stroke-associated pneumonia Page:589—593
97. Cerebral small vessel disease imaging markers predict hematoma expansion in patients with spontaneous intracerebral hemorrhage Page:594—601
98. Relationship between cerebral small vessel disease and the outcome after intravascular thrombectomy in patients with acute ischemic stroke Page:602—607
99. Effect of renal insufficiency on the treatment of patients with ischemic stroke Page:608—612
100. Pathophysiological mechanism of vascular cognitive impairment Page:613—618
101. Endovascular embolization device for intracranial aneurysm Page:619—624
102. Venous sinus stenting for treatment of idiopathic intracranial hypertension Page:625—629
103. Mechanism of period gene regulating renin-angiotensin-aldosterone system in rhythm of blood pressure Page:630—635
104. Correlation between white matter hyperintensities and collateral circulation in patients with stroke caused by anterior circulation large vessel occlusion Page:654—658
105. Serum C-type lectin-like receptor-2 combined with insulin resistance predicts the outcome of patients with acute ischemic stroke after intravenous thrombolysis Page:659—665
106. Correlation between metabolic syndrome and early neurological deterioration in patients with minor stroke or high-risk transient ischemic attack Page:666—670
107. Outcomes and influencing factors of acute ischemic stroke complicated with active cancer Page:671—676
108. Characteristics of total cerebral small vessel disease burden in octogenarians with cerebral small vessel disease and its relation with serum uric acid levels Page:677—684
109. Elastase injection into the cerebellomedullary cistern to induce a model of vertebrobasilar dolichoectasia in mice and evaluation of magnetic resonance angiography Page:685—688
110. Thalamic infarction and cognitive impairment Page:689—692
111. Interleukin-18 and post-stroke depression Page:693—697
112. Targeted ion channel therapy for acute ischemic stroke and cerebral edema Page:698—702
113. Predictors of early neurological deterioration in patients with acute ischemic stroke based on OCSP classification system Page:725—731
114. Correlation between fibrinogen and lipoprotein (a) and early neurological deterioration in acute ischemic stroke patients with diabetes Page:732—737
115. Correlation between door-to-needle time and short-term outcome of minor ischemic stroke Page:738—743
116. Seasonal changes of glycated hemoglobin in patients with acute ischemic stroke in Tianjin Page:744—749
117. Tubridge flow diverter for the treatment of recurrent internal carotid blood blister-like aneurysms after stent-assisted embolization Page:750—754
118. MiR-26a promotes angiogenesis in rats with cerebral ischemia through PI3K/Akt pathway Page:755—764
119. Glycated hemoglobin and outcomes of patients with acute ischemic stroke Page:765—769
120. Sudden sensorineural hearing loss and ischemic stroke Page:770—775
121. Endothelin-1 gene Lys198Asn polymorphism and ischemic stroke Page:776—780
122. T Helper cell 17/regulatory T cell balance and ischemic stroke Page:781—784
123. Neurobiological mechanism of post-stroke depression Page:785—788
124. Diagnosis and treatment of post-stroke depression Page:789—792
125. Efficacy, safety and cost-effectiveness of flow diverters in the treatment of intracranial aneurysms Page:793—796
126. Regional leptomeningeal collateral score on CT angiography predicts the outcome after endovascular therapy in patients with late window anterior circulation stroke Page:805—811
127. Correlation between white matter hyperintensities and the outcomes after reperfusion therapy in patients with acute ischemic stroke Page:812—819
128. Correlation between total cholesterol/high-density lipoprotein cholesterol ratio and asymptomatic carotid atherosclerotic plaque stability Page:820—824
129. Endovascular recanalization for symptomatic chronic internal carotid artery occlusion: a study of 19 cases Page:825—829
130. Correlation between diabetic peripheral neuropathy and overall burden of cerebral small vessel disease in patients with type 2 diabetes Page:830—836
131. Correlation between gut microbiota, short-chain fatty acids metabolic disorder and outcomes of patients with hypertensive intracerebral hemorrhage Page:837—844
132. Role of microglia phagocytosis in acute ischemic stroke Page:845—849
133. Role of microglia in vascular cognitive impairment Page:850—854
134. Apolipoprotein E genotypes and vascular cognitive impairment Page:855—858
135. Intracranial arterial dolichoectasia and cerebral small vessel disease Page:859—863
136. Clinical outcome scoring scale for intracerebral hemorrhage Page:864—868
137. Stress hyperglycemia predicts the outcomes in patients with acute ischemic stroke Page:885—892
138. Serum miR-195 and miR-599 predict the outcome of patients with acute ischemic stroke Page:893—897
139. High-sensitivity C-reactive protein and lipoprotein-associated phospholipase A 2 predict early neurological deterioration and hemorrhagic transformation after intravenous thrombolysis in patients with acute ischemic stroke Page:898—903
140. STAF score predict paroxysmal atrial fibrillation in patients with recurrent acute ischemic stroke Page:904—909
141. Seasonal changes of fasting plasma glucose levels in patients with acute ischemic stroke in Tianjin Page:910—913
142. Rutin attenuates early brain injury after subarachnoid hemorrhage in rats by protecting blood-brain barrier Page:914—919
143. Effectiveness of exogenous melatonin on delirium in critically ill patients: a meta-analysis Page:920—925
144. Capsular warning syndrome Page:926—930
145. Effect of treatment of acute ischemic stroke on cognitive function Page:931—934
146. Mechanisms of cognitive impairment and dementia in patients with atrial fibrillation Page:935—938
147. Preventive effect of anticoagulant therapy and catheter ablation on dementia in patients with atrial fibrillation Page:939—942
148. Estrogen and white matter hyperintensities Page:943—947

©2019 - Present World Health Organization Regional Office for the Western Pacific. All Rights Reserved.